Hair loss is a common problem in clinical dermatology, with many aetiologies including but not limited to androgenetic ...

(Reuters) -Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce ...

Key efficacy and safety recommendations were as follows [104]: "...weight loss and weight maintenance should be demonstrated over the course of at least 1 year before a product can be considered ...